Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-08022025-260850
EXTRAORDINARY
PART I-Section 1
PUBLISHED BY AUTHORITY
No. 39]
NEW DELHI, FRIDAY, FEBRUARY 7, 2025/MAGHA 18, 1946
972 GI/2025
MINISTRY OF COMMERCE AND INDUSTRY
(Department of Commerce)
(DIRECTORATE GENERAL OF FOREIGN TRADE)
PUBLIC NOTICE
New Delhi, the 6th February, 2025
No. 46/2024-25
Subject: Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin
Stearate Tablet.
F. No. 01/82/0017/AM-25/DES-III.— In exercise of the powers conferred under paragraphs 1.03 and 2.04 of
the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the
following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
+-----------------------------------+----------------+---------+----------------+----------+
| Export Product | Quantity | Sl. No. | Import Item/s | Quantity |
+===================================+================+=========+================+==========+
| Erythromycin Stearate tablets-250 | 1 Number Tablet| 1 | Erythromycin | 334 mg. |
| mg. | | | Stearate | |
| (each tablet contains erythromycin | | | | |
| stearate equivalent to 250 mg. of | | | | |
| Erythromycin | | | | |
+-----------------------------------+----------------+---------+----------------+----------+
Note: For other variants of export items, norms may be worked out on a pro-rata basis.
Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with
immediate effect.
SANTOSH KUMAR SARANGI, Director General of Foreign Trade Ex-officio Addl. Secy.